TABLE 2

Characteristics of the patients in the IGT and NGT groups

IGT group
NGT group
Preoperative3 months6 months12 monthsPreoperative3 months6 months12 months
n55558468
M/F0/50/8
Age (years)37.8 ± 4.334.1 ± 3.3
Weight (kg)125.7 ± 10.596.6 ± 9.183.5 ± 9.374.4 ± 7.8124.9 ± 6.2100.7 ± 5.288.4 ± 5.077.9 ± 4.8
BMI (kg/m2)52.2 ± 3.739.8 ± 4.634.4 ± 4.830.7 ± 3.446.6 ± 1.836.7 ± 1.733.0 ± 1.928.4 ± 1.7
FFM (kg)65.2 ± 4.561.1 ± 3.955.8 ± 3.554.5 ± 2.365.1 ± 2.557.8 ± 1.954.8 ± 1.655.6 ± 1.5
Fat mass (kg)60.6 ± 7.035.3 ± 7.327.7 ± 8.019.8 ± 6.559.3 ± 4.043.0 ± 3.633.6 ± 3.722.3 ± 3.7
Fasting glucose (mmol/l)6.1 ± 0.19 (5.6–6.6)4.2 ± 0.29 (3.1–4.7)4.4 ± 0.23 (3.7–4.9)4.5 ± 0.30 (3.8–5.6)4.9 ± 0.12 (4.3–5.4)4.3 ± 0.16 (3.9–4.7)3.9 ± 0.12 (3.5–4.3)4.1 ± 0.08 (3.8–4.5)
Fasting insulin (pmol/l)172.2 ± 17.448.0 ± 18.640.2 ± 13.849.2 ± 14.479.1 ± 13.645.7 ± 3.633.9 ± 7.734.6 ± 4.4
QUICKI0.286 ± 0.0050.378 ± 0.0180.416 ± 0.0340.377 ± 0.0280.33 ± 0.0070.360 ± 0.0070.396 ± 0.0150.385 ± 0.009
1st phase insulin (pmol/l)276.0 ± 51.6246.6 ± 55.2392.4 ± 147.0372.6 ± 87.0659.6 ± 60.2356.4 ± 23.3428.8 ± 126.9393.1 ± 92.8
2nd phase insulin (pmol/l)532.2 ± 120.6272.4 ± 87.0246.6 ± 102.6243.6 ± 78.6429.3 ± 86.0206.4 ± 36.6237.9 ± 89.9167.7 ± 40.9
  • Data are means ± SE (range) unless otherwise indicated.